Adamis Pharmaceuticals Corporation ADMP was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $2.27 to $3.05 in the past one-month time frame.
The company has not seen any estimate revision in the past month, while the Zacks Consensus Estimate has moved lower over the same time frame, suggesting there may be trouble down the road. So, make sure to keep an eye on this stock going forward, to see if this recent move higher can last.
Adamis Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Adamis Pharmaceuticals Corporation Price
Adamis Pharmaceuticals Corporation Price | Adamis Pharmaceuticals Corporation Quote
Investors interested in the Medical - Drugs industry may consider Melinta Therapeutics, Inc. MLNT, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is ADMP going up? Or down? Predict to see what others think:Up or Down
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Adamis Pharmaceuticals Corporation (ADMP) : Free Stock Analysis Report
Melinta Therapeutics, Inc. (MLNT) : Free Stock Analysis Report
To read this article on Zacks.com click here.